Fineline Cube

Follow:
14778 Articles
CanSino Biologics' DTcP Vaccine for Infants and Young Children Accepted by NMPA for Review
CompanyDrug

CanSino Biologics’ DTcP Vaccine for Infants and Young Children Accepted by NMPA for Review

MicroPort NeuroTech Leads Investment Fund to Advance Brain Science Industry
CompanyDeals

MicroPort NeuroTech Leads Investment Fund to Advance Brain Science Industry

Candid Therapeutics Expands TCE Portfolio with Strategic Partnerships in Autoimmune Disease Treatment
CompanyDeals

Candid Therapeutics Expands TCE Portfolio with Strategic Partnerships in Autoimmune Disease Treatment

EMA Grants PRIME Designation to Hansoh Pharmaceutical's HS-20093 in Collaboration with GSK
CompanyDrug

EMA Grants PRIME Designation to Hansoh Pharmaceutical’s HS-20093 in Collaboration with GSK

Bio-Thera Solutions Expands License Deal with SteinCares for Latin American Market
CompanyDeals

Bio-Thera Solutions Expands License Deal with SteinCares for Latin American Market

European CHMP Supports Conditional Approval of MSD's Welireg for VHL Disease and RCC
CompanyDrug

European CHMP Supports Conditional Approval of MSD’s Welireg for VHL Disease and RCC

EMA's CHMP Recommends Approval of Bayer's Acoramidis for ATTR-CM Treatment
CompanyDrug

EMA’s CHMP Recommends Approval of Bayer’s Acoramidis for ATTR-CM Treatment

Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities
Policy / Regulatory

Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities

Sanofi's Tolebrutinib Earns FDA Breakthrough Designation for Non-Relapsing Secondary Progressive MS
CompanyDrug

Sanofi’s Tolebrutinib Earns FDA Breakthrough Designation for Non-Relapsing Secondary Progressive MS

Roche's cobas 6800/8800 Systems 2.0 Earn CE Certification, Set for US Market Entry
CompanyMedical Device

Roche’s cobas 6800/8800 Systems 2.0 Earn CE Certification, Set for US Market Entry

ARS Pharmaceuticals' Neffy Receives Market Filings in Asia-Pacific Region
CompanyDrug

ARS Pharmaceuticals’ Neffy Receives Market Filings in Asia-Pacific Region

Fujian Cosunter Pharmaceutical's GST-HG141 Earns Breakthrough Designation for Chronic Hepatitis B
CompanyDrug

Fujian Cosunter Pharmaceutical’s GST-HG141 Earns Breakthrough Designation for Chronic Hepatitis B